Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 473 entries
Sorted by: Best Match Show Resources per page
Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area.

Annals of Indian Academy of Neurology

Badr HI, Shaker AA, Mansour MA, Kasem MA, Zaher AA, Salama HH, Safwat MI.
PMID: 21808472
Ann Indian Acad Neurol. 2011 Apr;14(2):107-10. doi: 10.4103/0972-2327.82796.

BACKGROUND: After malaria, schistosomiasis is the second most prevalent tropical disease. The prevalence of oviposition in CNS of infected persons varies from 0.3 to 30%. The conus medullaris is a primary site of schistosomiasis, either granulomatous or acute necrotizing...

Cite
Badr HI, Shaker AA, Mansour MA, et al. Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area. Ann Indian Acad Neurol. 2011;14(2):107-10doi: 10.4103/0972-2327.82796.
Badr, H. I., Shaker, A. A., Mansour, M. A., Kasem, M. A., Zaher, A. A., Salama, H. H., & Safwat, M. I. (2011). Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area. Annals of Indian Academy of Neurology, 14(2), 107-10. https://doi.org/10.4103/0972-2327.82796
Badr, Hatem I, et al. "Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area." Annals of Indian Academy of Neurology vol. 14,2 (2011): 107-10. doi: https://doi.org/10.4103/0972-2327.82796
Badr HI, Shaker AA, Mansour MA, Kasem MA, Zaher AA, Salama HH, Safwat MI. Schistosomal myeloradiculopathy due to Schistosoma mansoni: Report on 17 cases from an endemic area. Ann Indian Acad Neurol. 2011 Apr;14(2):107-10. doi: 10.4103/0972-2327.82796. PMID: 21808472; PMCID: PMC3141472.
Copy Download .nbib Format: NLM
Coherent frequency conversion in a superconducting artificial atom with two internal degrees of freedom.

Physical review letters

Lecocq F, Pop IM, Matei I, Dumur E, Feofanov AK, Naud C, Guichard W, Buisson O.
PMID: 22463441
Phys Rev Lett. 2012 Mar 09;108(10):107001. doi: 10.1103/PhysRevLett.108.107001. Epub 2012 Mar 05.

By adding a large inductance in a dc-SQUID phase qubit loop, one decouples the junctions' dynamics and creates a superconducting artificial atom with two internal degrees of freedom. In addition to the usual symmetric plasma mode (s mode) which...

Cite
Lecocq F, Pop IM, Matei I, et al. Coherent frequency conversion in a superconducting artificial atom with two internal degrees of freedom. Phys Rev Lett. 2012;108(10):107001doi: 10.1103/PhysRevLett.108.107001.
Lecocq, F., Pop, I. M., Matei, I., Dumur, E., Feofanov, A. K., Naud, C., Guichard, W., & Buisson, O. (2012). Coherent frequency conversion in a superconducting artificial atom with two internal degrees of freedom. Physical review letters, 108(10), 107001. https://doi.org/10.1103/PhysRevLett.108.107001
Lecocq, F, et al. "Coherent frequency conversion in a superconducting artificial atom with two internal degrees of freedom." Physical review letters vol. 108,10 (2012): 107001. doi: https://doi.org/10.1103/PhysRevLett.108.107001
Lecocq F, Pop IM, Matei I, Dumur E, Feofanov AK, Naud C, Guichard W, Buisson O. Coherent frequency conversion in a superconducting artificial atom with two internal degrees of freedom. Phys Rev Lett. 2012 Mar 09;108(10):107001. doi: 10.1103/PhysRevLett.108.107001. Epub 2012 Mar 05. PMID: 22463441.
Copy Download .nbib Format: NLM
A TeNaCious foundation for the metastatic niche.

Cancer cell

Matei I, Ghajar CM, Lyden D.
PMID: 21840480
Cancer Cell. 2011 Aug 16;20(2):139-41. doi: 10.1016/j.ccr.2011.08.004.

In the July issue of Nature Medicine, Massagué and colleagues define a biphasic role for the extracellular matrix protein tenascin C as a metastatic niche component in lung colonization by breast cancer cells. These results provide a rationale for...

Cite
Matei I, Ghajar CM, Lyden D. A TeNaCious foundation for the metastatic niche. Cancer Cell. 2011;20(2):139-41doi: 10.1016/j.ccr.2011.08.004.
Matei, I., Ghajar, C. M., & Lyden, D. (2011). A TeNaCious foundation for the metastatic niche. Cancer cell, 20(2), 139-41. https://doi.org/10.1016/j.ccr.2011.08.004
Matei, Irina, et al. "A TeNaCious foundation for the metastatic niche." Cancer cell vol. 20,2 (2011): 139-41. doi: https://doi.org/10.1016/j.ccr.2011.08.004
Matei I, Ghajar CM, Lyden D. A TeNaCious foundation for the metastatic niche. Cancer Cell. 2011 Aug 16;20(2):139-41. doi: 10.1016/j.ccr.2011.08.004. PMID: 21840480.
Copy Download .nbib Format: NLM
Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis.

International journal of endocrinology

Stagi S, Pucci N, Di Grande L, de Libero C, Caputo R, Pantano S, Mattei I, Mori F, de Martino M, Novembre E.
PMID: 25140177
Int J Endocrinol. 2014;2014:804870. doi: 10.1155/2014/804870. Epub 2014 Jul 20.

Hormones may play a role in the pathophysiology of vernal keratoconjunctivitis (VKC). An increased incidence of thyroid autoantibodies was recently observed in VKC, although there were no data on thyroid function. Two hundred and eighty-eight patients (202 males, 86...

Cite
Stagi S, Pucci N, Di Grande L, et al. Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis. Int J Endocrinol. 2014;2014:804870doi: 10.1155/2014/804870.
Stagi, S., Pucci, N., Di Grande, L., de Libero, C., Caputo, R., Pantano, S., Mattei, I., Mori, F., de Martino, M., & Novembre, E. (2014). Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis. International journal of endocrinology, 2014804870. https://doi.org/10.1155/2014/804870
Stagi, Stefano, et al. "Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis." International journal of endocrinology vol. 2014 (2014): 804870. doi: https://doi.org/10.1155/2014/804870
Stagi S, Pucci N, Di Grande L, de Libero C, Caputo R, Pantano S, Mattei I, Mori F, de Martino M, Novembre E. Increased incidence of thyroid dysfunction and autoimmunity in patients with vernal keratoconjunctivitis. Int J Endocrinol. 2014;2014:804870. doi: 10.1155/2014/804870. Epub 2014 Jul 20. PMID: 25140177; PMCID: PMC4130298.
Copy Download .nbib Format: NLM
The peer review process for awarding funds to international science research consortia: a qualitative developmental evaluation.

F1000Research

Gregorius S, Dean L, Cole DC, Bates I.
PMID: 29333239
F1000Res. 2017 Oct 06;6:1808. doi: 10.12688/f1000research.12496.1. eCollection 2017.

No abstract available.

Cite
Gregorius S, Dean L, Cole DC, et al. The peer review process for awarding funds to international science research consortia: a qualitative developmental evaluation. F1000Res. 2017;6:1808doi: 10.12688/f1000research.12496.1.
Gregorius, S., Dean, L., Cole, D. C., & Bates, I. (2017). The peer review process for awarding funds to international science research consortia: a qualitative developmental evaluation. F1000Research, 61808. https://doi.org/10.12688/f1000research.12496.1
Gregorius, Stefanie, et al. "The peer review process for awarding funds to international science research consortia: a qualitative developmental evaluation." F1000Research vol. 6 (2017): 1808. doi: https://doi.org/10.12688/f1000research.12496.1
Gregorius S, Dean L, Cole DC, Bates I. The peer review process for awarding funds to international science research consortia: a qualitative developmental evaluation. F1000Res. 2017 Oct 06;6:1808. doi: 10.12688/f1000research.12496.1. eCollection 2017. PMID: 29333239; PMCID: PMC5750705.
Copy Download .nbib Format: NLM
Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.

European journal of breast health

Jatoi I.
PMID: 30288491
Eur J Breast Health. 2018 Oct 01;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct.

Genetic testing is now widely utilized to identify women with a hereditary predisposition for breast cancer. Women who carry mutations that increase breast cancer risk may consider three options to reduce risk: screening, chemoprevention, and prophylactic surgery. Yet, no...

Cite
Jatoi I. Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition. Eur J Breast Health. 2018;14(4):189-193doi: 10.5152/ejbh.2018.4324.
Jatoi, I. (2018). Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition. European journal of breast health, 14(4), 189-193. https://doi.org/10.5152/ejbh.2018.4324
Jatoi, Ismail. "Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition." European journal of breast health vol. 14,4 (2018): 189-193. doi: https://doi.org/10.5152/ejbh.2018.4324
Jatoi I. Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition. Eur J Breast Health. 2018 Oct 01;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct. PMID: 30288491; PMCID: PMC6170022.
Copy Download .nbib Format: NLM
Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018.

Journal of pharmaceutical policy and practice

Rutter V, Chan AHY, Tuck C, Bader L, Babar ZU, Bates I.
PMID: 29651337
J Pharm Policy Pract. 2018 Apr 11;11:10. doi: 10.1186/s40545-018-0140-3. eCollection 2018.

The biennial Commonwealth Heads of Government Meeting (CHOGM) this year is based around four key themes: prosperity, fairness, sustainability and security. This is an opportune time to consider the role of pharmacists in healthcare delivery, and particularly their contribution...

Cite
Rutter V, Chan AHY, Tuck C, et al. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018;11:10doi: 10.1186/s40545-018-0140-3.
Rutter, V., Chan, A. H. Y., Tuck, C., Bader, L., Babar, Z. U., & Bates, I. (2018). Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. Journal of pharmaceutical policy and practice, 1110. https://doi.org/10.1186/s40545-018-0140-3
Rutter, Victoria, et al. "Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018." Journal of pharmaceutical policy and practice vol. 11 (2018): 10. doi: https://doi.org/10.1186/s40545-018-0140-3
Rutter V, Chan AHY, Tuck C, Bader L, Babar ZU, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018 Apr 11;11:10. doi: 10.1186/s40545-018-0140-3. eCollection 2018. PMID: 29651337; PMCID: PMC5896036.
Copy Download .nbib Format: NLM
Assessment of Affect Lability: Psychometric Properties of the ALS-18.

Frontiers in psychology

Contardi A, Imperatori C, Amati I, Balsamo M, Innamorati M.
PMID: 29651267
Front Psychol. 2018 Mar 29;9:427. doi: 10.3389/fpsyg.2018.00427. eCollection 2018.

Affect lability, an important aspect of emotion dysregulation, characterizes several psychiatric conditions. The short Affective Lability Scales (ALS-18) measures three aspects of changeability between euthymia and affect states (Anxiety/Depression, AD; Depression/Elation, DE; and Anger, Ang). The aim of our...

Cite
Contardi A, Imperatori C, Amati I, et al. Assessment of Affect Lability: Psychometric Properties of the ALS-18. Front Psychol. 2018;9:427doi: 10.3389/fpsyg.2018.00427.
Contardi, A., Imperatori, C., Amati, I., Balsamo, M., & Innamorati, M. (2018). Assessment of Affect Lability: Psychometric Properties of the ALS-18. Frontiers in psychology, 9427. https://doi.org/10.3389/fpsyg.2018.00427
Contardi, Anna, et al. "Assessment of Affect Lability: Psychometric Properties of the ALS-18." Frontiers in psychology vol. 9 (2018): 427. doi: https://doi.org/10.3389/fpsyg.2018.00427
Contardi A, Imperatori C, Amati I, Balsamo M, Innamorati M. Assessment of Affect Lability: Psychometric Properties of the ALS-18. Front Psychol. 2018 Mar 29;9:427. doi: 10.3389/fpsyg.2018.00427. eCollection 2018. PMID: 29651267; PMCID: PMC5885065.
Copy Download .nbib Format: NLM
Role of Optimal Medication Given to Patients with Hypertension and Ischemic Heart Disease Prior to an Acute Coronary Syndrome.

Heart international

Pop C, Florescu R, Matei C, Pop L, Manea V, Cotoraci C, Mos L, Petris A.
PMID: 30263100
Heart Int. 2017 Oct 14;12(1). doi: 10.5301/heartint.5000237. eCollection 2017.

INTRODUCTION: Administering optimal cardiovascular medication (OCM) to patients with hypertension (HBP) and ischemic heart disease (IHD) lowers cardiovascular morbidity and mortality.The main objective of this study was to compare in-hospital cardiac mortality among patients with HBP and/or IHD, treated...

Cite
Pop C, Florescu R, Matei C, et al. Role of Optimal Medication Given to Patients with Hypertension and Ischemic Heart Disease Prior to an Acute Coronary Syndrome. Heart Int. 2017;12(1)doi: 10.5301/heartint.5000237.
Pop, C., Florescu, R., Matei, C., Pop, L., Manea, V., Cotoraci, C., Mos, L., & Petris, A. (2017). Role of Optimal Medication Given to Patients with Hypertension and Ischemic Heart Disease Prior to an Acute Coronary Syndrome. Heart international, 12(1), . https://doi.org/10.5301/heartint.5000237
Pop, Călin, et al. "Role of Optimal Medication Given to Patients with Hypertension and Ischemic Heart Disease Prior to an Acute Coronary Syndrome." Heart international vol. 12,1 (2017). doi: https://doi.org/10.5301/heartint.5000237
Pop C, Florescu R, Matei C, Pop L, Manea V, Cotoraci C, Mos L, Petris A. Role of Optimal Medication Given to Patients with Hypertension and Ischemic Heart Disease Prior to an Acute Coronary Syndrome. Heart Int. 2017 Oct 14;12(1). doi: 10.5301/heartint.5000237. eCollection 2017. PMID: 30263100; PMCID: PMC6159667.
Copy Download .nbib Format: NLM
Preface to the special issue of the 4th Forum Carpaticum conference "Future of the Carpathians: Smart, Sustainable, Inclusive".

The Science of the total environment

Badea O, Matei E, Paoletti E.
PMID: 28750226
Sci Total Environ. 2017 Dec 31;609:160. doi: 10.1016/j.scitotenv.2017.07.110. Epub 2017 Jul 26.

No abstract available.

Cite
Badea O, Matei E, Paoletti E. Preface to the special issue of the 4th Forum Carpaticum conference "Future of the Carpathians: Smart, Sustainable, Inclusive". Sci Total Environ. 2017;609:160doi: 10.1016/j.scitotenv.2017.07.110.
Badea, O., Matei, E., & Paoletti, E. (2017). Preface to the special issue of the 4th Forum Carpaticum conference "Future of the Carpathians: Smart, Sustainable, Inclusive". The Science of the total environment, 609160. https://doi.org/10.1016/j.scitotenv.2017.07.110
Badea, Ovidiu, et al. "Preface to the special issue of the 4th Forum Carpaticum conference "Future of the Carpathians: Smart, Sustainable, Inclusive"." The Science of the total environment vol. 609 (2017): 160. doi: https://doi.org/10.1016/j.scitotenv.2017.07.110
Badea O, Matei E, Paoletti E. Preface to the special issue of the 4th Forum Carpaticum conference "Future of the Carpathians: Smart, Sustainable, Inclusive". Sci Total Environ. 2017 Dec 31;609:160. doi: 10.1016/j.scitotenv.2017.07.110. Epub 2017 Jul 26. PMID: 28750226.
Copy Download .nbib Format: NLM
Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

Nature communications

Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R.
PMID: 29600804
Nat Commun. 2018 Mar 30;9:16211. doi: 10.1038/ncomms16211.

This corrects the article DOI: 10.1038/ncomms15908.

Cite
Zhang X, Chiang HC, Wang Y, et al. Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis. Nat Commun. 2018;9:16211doi: 10.1038/ncomms16211.
Zhang, X., Chiang, H. C., Wang, Y., Zhang, C., Smith, S., Zhao, X., Nair, S. J., Michalek, J., Jatoi, I., Lautner, M., Oliver, B., Wang, H., Petit, A., Soler, T., Brunet, J., Mateo, F., Angel Pujana, M., Poggi, E., Chaldekas, K., Isaacs, C., Peshkin, B. N., Ochoa, O., Chedin, F., Theoharis, C., Sun, L. Z., Curiel, T. J., Elledge, R., Jin, V. X., Hu, Y., & Li, R. (2018). Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis. Nature communications, 916211. https://doi.org/10.1038/ncomms16211
Zhang, Xiaowen, et al. "Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis." Nature communications vol. 9 (2018): 16211. doi: https://doi.org/10.1038/ncomms16211
Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R. Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis. Nat Commun. 2018 Mar 30;9:16211. doi: 10.1038/ncomms16211. PMID: 29600804; PMCID: PMC5882462.
Copy Download .nbib Format: NLM
Order in Chaos: Understanding Intratumoral Heterogeneity in Gliomas by Tracking Tumor Cell Fate.

Neurosurgery

Banu MA, McKhann GM.
PMID: 29244136
Neurosurgery. 2018 Jan 01;82(1):N4-N6. doi: 10.1093/neuros/nyx538.

No abstract available.

Cite
Banu MA, McKhann GM. Order in Chaos: Understanding Intratumoral Heterogeneity in Gliomas by Tracking Tumor Cell Fate. Neurosurgery. 2018;82(1):N4-N6doi: 10.1093/neuros/nyx538.
Banu, M. A., & McKhann, G. M. (2018). Order in Chaos: Understanding Intratumoral Heterogeneity in Gliomas by Tracking Tumor Cell Fate. Neurosurgery, 82(1), N4-N6. https://doi.org/10.1093/neuros/nyx538
Banu, Matei A, and McKhann, Guy M. "Order in Chaos: Understanding Intratumoral Heterogeneity in Gliomas by Tracking Tumor Cell Fate." Neurosurgery vol. 82,1 (2018): N4-N6. doi: https://doi.org/10.1093/neuros/nyx538
Banu MA, McKhann GM. Order in Chaos: Understanding Intratumoral Heterogeneity in Gliomas by Tracking Tumor Cell Fate. Neurosurgery. 2018 Jan 01;82(1):N4-N6. doi: 10.1093/neuros/nyx538. PMID: 29244136.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 473 entries